Free Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertileSix years later, she is well—and pregnant with her third child May 02, 2025Vol.51 No.17By Jacquelyn Cobb
White House The White House “skinny budget” document cuts NIH by nearly 40%The cuts are consistent with the previously leaked “passback” document May 02, 2025Vol.51 No.17By Jacquelyn Cobb and Claire Marie Porter
News Analysis NIH eliminates the NCI Board of Scientific AdvisorsOver its 28 year history, BSA shaped NCI-funded extramural science May 02, 2025Vol.51 No.17By Paul Goldberg
Capitol Hill NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”Cancer research also took center stage at Senate appropriations hearing May 02, 2025Vol.51 No.17By Claire Marie Porter
Bertagnolli: NIH funding cuts are “unprecedented and harmful”AACR panel challenges scientists to find stability in a period of “ventricular tachycardia” May 02, 2025Vol.51 No.17By Claire Marie Porter
Sponsored Advancing quality of life in oncology: A journey of compassion and innovation May 02, 2025Vol.51 No.17By Betty Ferrell
Conversation with The Cancer Letter Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health April 25, 2025Vol.51 No.16By Paul Goldberg
Guest Editorial In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same April 25, 2025Vol.51 No.16By W. Kimryn Rathmell
Regulatory News Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas April 25, 2025Vol.51 No.16By Claire Marie Porter
Sponsored Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI April 25, 2025Vol.51 No.16By Suresh S. Ramalingam and Adam Marcus
